| A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications GW Wright, JD Phelan, ZA Coulibaly, S Roulland, RM Young, JQ Wang, ... Cancer cell 37 (4), 551-568. e14, 2020 | 818 | 2020 |
| Conserved pan-cancer microenvironment subtypes predict response to immunotherapy A Bagaev, N Kotlov, K Nomie, V Svekolkin, A Gafurov, O Isaeva, N Osokin, ... Cancer cell 39 (6), 845-865. e7, 2021 | 660 | 2021 |
| Clinical and biological subtypes of B-cell lymphoma revealed by microenvironmental signatures N Kotlov, A Bagaev, MV Revuelta, JM Phillip, MT Cacciapuoti, ... Cancer discovery 11 (6), 1468-1489, 2021 | 152 | 2021 |
| Elevated pre-activation basal level of nuclear NF-κB in native macrophages accelerates LPS-induced translocation of cytosolic NF-κB into the cell nucleus AV Bagaev, AY Garaeva, ES Lebedeva, AV Pichugin, RI Ataullakhanov, ... Scientific reports 9 (1), 4563, 2019 | 86 | 2019 |
| Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes A Zaitsev, M Chelushkin, D Dyikanov, I Cheremushkin, B Shpak, K Nomie, ... Cancer Cell 40 (8), 879-894. e16, 2022 | 63 | 2022 |
| Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax®, as a therapeutic strategy for metastatic breast cancer A Ghochikyan, A Pichugin, A Bagaev, A Davtyan, A Hovakimyan, ... Journal of Translational Medicine 12, 1-12, 2014 | 54 | 2014 |
| Follicular lymphoma microenvironment characteristics associated with tumor cell mutations and MHC class II expression G Han, Q Deng, ML Marques-Piubelli, E Dai, M Dang, MCJ Ma, X Li, ... Blood cancer discovery 3 (5), 428-443, 2022 | 45 | 2022 |
| Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations F Li, L Deng, KR Jackson, AH Talukder, AS Katailiha, SD Bradley, Q Zou, ... Journal for immunotherapy of cancer 9 (7), 2021 | 41 | 2021 |
| Primary 4T1 tumor resection provides critical “window of opportunity” for immunotherapy A Ghochikyan, A Davtyan, A Hovakimyan, H Davtyan, A Poghosyan, ... Clinical & experimental metastasis 31, 185-198, 2014 | 39 | 2014 |
| Lack of intrafollicular memory CD4+ T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma P Mondello, A Fama, MC Larson, AL Feldman, JC Villasboas, ZZ Yang, ... Blood cancer journal 11 (7), 130, 2021 | 37 | 2021 |
| Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts I Tutykhina, I Esmagambetov, A Bagaev, A Pichugin, A Lysenko, ... PLoS One 13 (1), e0191574, 2018 | 36 | 2018 |
| Systems and methods for generating, visualizing and classifying molecular functional profiles A Bagaev, F Frenkel, N Kotlov, R Ataullakhanov US Patent 10,311,967, 2019 | 23 | 2019 |
| Systems and methods for generating, visualizing and classifying molecular functional profiles A Bagaev, F Frenkel, N Kotlov, R Ataullakhanov, O Isaeva US Patent 11,367,509, 2022 | 22 | 2022 |
| Systems and methods for generating, visualizing and classifying molecular functional profiles A Bagaev, F Frenkel, N Kotlov, R Ataullakhanov, O Isaeva US Patent 11,322,226, 2022 | 21 | 2022 |
| Systems and methods for generating, visualizing and classifying molecular functional profiles A Bagaev, F Frenkel, N Kotlov, R Ataullakhanov, O Isaeva US Patent 11,430,545, 2022 | 19 | 2022 |
| Single-cell spatial proteomic revelations on the multiparametric MRI heterogeneity of clinically significant prostate cancer RK Pachynski, EH Kim, N Miheecheva, N Kotlov, A Ramachandran, ... Clinical Cancer Research 27 (12), 3478-3490, 2021 | 19 | 2021 |
| Systems and methods for generating, visualizing and classifying molecular functional profiles A Bagaev, F Frenkel, N Kotlov, R Ataullakhanov US Patent 10,650,911, 2020 | 19 | 2020 |
| Systems and methods for identifying responders and non-responders to immune checkpoint blockade therapy F Frenkel, N Kotlov, A Bagaev, M Artomov, R Ataullakhanov US Patent App. 16/006,085, 2018 | 17 | 2018 |
| Systems and methods for identifying cancer treatments from normalized biomarker scores A Bagaev, F Frenkel, R Ataullakhanov US Patent App. 16/006,200, 2018 | 17 | 2018 |
| Systems and methods for identifying cancer treatments from normalized biomarker scores A Bagaev, F Frenkel, R Ataullakhanov US Patent 10,340,031, 2019 | 16 | 2019 |
Nikita KotlovBostonGene在 bostongene.com 的电子邮件经过验证
Nikita KotlovBostonGene在 bostongene.com 的电子邮件经过验证